Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Meregalli

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Biological Regulators and Homeostatic Agents|October 1, 1996
Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretionP Lissoni, F Rovelli, L Giani, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
British Journal of Cancer|July 17, 1999
Pretreatment serum markers and lymphocyte response to interleukin-2 therapyL Fumagalli, P Lissoni, G Di Felice, et al.
The International Journal of Biological Markers|March 18, 1999
Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic diseaseP Lissoni, F Rovelli, L Giani, et al.
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
Tumori|June 10, 1998
Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancerS Barni, P Lissoni, S Meregalli, et al.
Oncology Reports|May 21, 2011
A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patientsP Lissoni, A Ardizzoia, S Barni, et al.
Neuropediatrics|February 24, 2001
Intermittent falls and fecal incontinence as a manifestation of epileptic negative myoclonus in idiopathic partial epilepsy of childhoodG Capovilla, G Rubboli, F Beccaria, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Biological Regulators and Homeostatic Agents|October 1, 1996
Correlation between IL-12 and IL-2 blood levels in the metastatic neoplastic disease: a possible inhibitory feedback system regulating their secretionP Lissoni, F Rovelli, L Giani, et al.
Tumori|December 31, 1994
A randomized study of immunotherapy with low-dose subcutaneous interleukin-2 plus melatonin vs chemotherapy with cisplatin and etoposide as first-line therapy for advanced non-small cell lung cancerP Lissoni, S Meregalli, V Fossati, et al.
Oncology|January 1, 1996
Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy aloneP Lissoni, S Meregalli, L Nosetto, et al.
British Journal of Cancer|July 17, 1999
Pretreatment serum markers and lymphocyte response to interleukin-2 therapyL Fumagalli, P Lissoni, G Di Felice, et al.
The International Journal of Biological Markers|March 18, 1999
Dehydroepiandrosterone sulfate (DHEAS) secretion in early and advanced solid neoplasms: selective deficiency in metastatic diseaseP Lissoni, F Rovelli, L Giani, et al.
The International Journal of Biological Markers|July 17, 2008
Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastasesP Lissoni, S Meregalli, S Curreri, et al.
Journal of Biological Regulators and Homeostatic Agents|May 16, 1998
Melatonin as a new possible anti-inflammatory agentP Lissoni, F Rovelli, S Meregalli, et al.
Tumori|June 10, 1998
Clinical efficacy of the aromatase inhibitor anastrozole in relation to prolactin secretion in heavily pretreated metastatic breast cancerS Barni, P Lissoni, S Meregalli, et al.
Oncology Reports|May 21, 2011
A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patientsP Lissoni, A Ardizzoia, S Barni, et al.
Neuropediatrics|February 24, 2001
Intermittent falls and fecal incontinence as a manifestation of epileptic negative myoclonus in idiopathic partial epilepsy of childhoodG Capovilla, G Rubboli, F Beccaria, et al.
Pageof 3